Effect of atorvastatin on C-reactive protein and benefits for cardiovascular disease in patients with type 2 diabetes: analyses from the Collaborative Atorvastatin Diabetes Trial

by Soedamah-Muthu, S.S., Livingstone, S.J., Charlton-Menys, V., Betteridge, D.J., Hitman, G.A., Neil, H.A.W., Bao, W., DeMicco, D.A., Preston, G.M., Fuller, J.H., Stehouwer, C.D.A., Schalkwijk, C.G., Durrington, P.N., Colhoun, H.M.